Indian Govt. Move To Scrutinize MNC Investments In Indian Firms Could have "Chilling" Effect
This article was originally published in The Pink Sheet Daily
Executive Summary
The development follows a relentless campaign launched over the last two years by the Indian Pharmaceutical Alliance, a powerful lobby of 17 large Indian companies.
You may also be interested in...
Indian Pharma Lobby Begins Fresh Offensive For Cap On Foreign Investments Into Domestic Companies
MUMBAI - As India's commerce and finance ministries wrangle over the viability of capping investments by global pharmaceutical companies into Indian generic firms, the Indian Pharmaceutical Alliance led a new offensive urging the government to tighten investment regulations
Not Selling Yet, Cipla Opposes Capping MNC-led Buyouts Of Indian Firms
MUMBAI - Cipla Ltd. Chairman Yusuf K. Hamied has tried to temper nagging speculation over a possible sell-off to a global company like Merck & Co. or Takeda Pharmaceutical Co. Ltd. He emphatically denied holding any negotiations and claimed he has never been approached for a potential transaction
India Story Tempered? Government May Put Future Brownfield Buyouts Under Scrutiny; No Qualms On Greenfield Investments
MUMBAI - Whether increased acquisitions of large Indian companies by multinational companies presents a threat to public health is being considered by a high-level inter-ministerial group that may approve provisions that distinguish between "greenfield" and "brownfield" investments made in India by external organizations or agencies